IndraLab

Statements


USP25 inhibits BRCA2. 1 / 1
| 1

reach
"Importantly, we provide evidence that a defect in USP21 mediated BRCA2 stabilization impairs the growth of BRCA2-proficient HCC tumor cells, and consistent with this, USP21 levels inversely correlate with HCC patient survival, pointing to USP21 as a potential target for HCC tumor therapy."